Capricor Therapeutics
CAPR
#5195
Rank
ยฃ1.23 B
Marketcap
ยฃ21.39
Share price
-2.40%
Change (1 day)
176.28%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -ยฃ78.43 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -ยฃ29.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -ยฃ77.83 Million159.57%
2024 -ยฃ29.99 Million81.57%
2023 -ยฃ16.52 Million-23.2%
2022 -ยฃ21.51 Million44.93%
2021 -ยฃ14.84 Million46.61%
2020 -ยฃ10.12 Million78.71%
2019 -ยฃ5.67 Million-49.7%
2018 -ยฃ11.26 Million-724.78%
2017 ยฃ1.8 M-112.93%
2016 -ยฃ13.94 Million46.27%
2015 -ยฃ9.53 Million106.82%
2014 -ยฃ4.61 Million-48.41%
2013 -ยฃ8.93 Million977.23%
2012 -ยฃ0.83 Million-77.11%
2011 -ยฃ3.63 Million-22.35%
2010 -ยฃ4.67 Million-20.17%
2009 -ยฃ5.85 Million-41.17%
2008 -ยฃ9.93 Million41.05%
2007 -ยฃ7.04 Million1098.87%
2006 -ยฃ0.59 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.24 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.59 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.62 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.56 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.04 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA